{"slug":"semax-nerve-damage","verification":{"valid":true,"entries":2,"head":"df1756db141df0ef9c37f786e48c0d1e103140f0a6f5e587342f1842962e7f86"},"energy":{"passes":2,"tokens_in":16759,"tokens_out":2543,"tokens_total":19302,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"df1756db141df0ef9c37f786e48c0d1e103140f0a6f5e587342f1842962e7f86"},"provenance":[{"ts":"2026-06-30T00:07:56.284Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Nerve Damage\nSlug: semax-nerve-damage\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n2. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n3. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target othe","response":"{\n  \"slug\": \"semax-nerve-damage\",\n  \"title\": \"Semax for Nerve Damage: Evidence Review\",\n  \"body\": \"## What's breaking down\\nNerve damage involves degeneration where breakdown of neurons, axons, or myelin outpaces natural repair. Layers include loss of trophic support like BDNF, inflammation after injury, impaired survival signaling during stress or ischemia, and reduced plasticity in affected neural circuits. If your nerve issue stems from these, repair-focused approaches target rebuilding connections rather than only suppressing symptoms.\\n\\n## Why Semax might help you\\n1. What keeps failing: BDNF decline reduces neuron survival and connection building after damage.\\n2. What Semax is studied to do: Studied for increasing BDNF expression and supporting neural repair pathways in models of injury.\\n3. Therefore for you: If BDNF or related neural support is part of your problem, Semax is discussed because it targets repair at the molecular level — not because it masks pain or reduces load.\\n\\n## How these fit together\\nSingle-compound focus. Semax maps to the neural repair layer. If your profile includes other factors, additional compounds would address separate layers such as inflammation or mechanical stress.\\n\\n## What the evidence actually shows\\nHuman data come from Russian studies on ischemic stroke recovery and glaucomatous optic neuropathy. One study found Semax improved functional recovery and motor performance in stroke patients (preclinical and human stroke data, mechanistic via gene expression). Another examined Semax in glaucoma patients with normalized eye pressure and noted neuroprotective effects (human, small scale).\\n\\nPreclinical data: Multiple rat studies show Semax increases BDNF mRNA and protein in hippocampus and cortex after ischemia or stress, enhances neuron survival under hypoxia or glutamate toxicity, and reduces infarct size in photothrombosis models (preclinical).\\n\\nNo large Western human trials specifically for peripheral nerve damage or","tokens_in":16759,"tokens_out":2543,"cost":0,"prev":"genesis","hash":"8daa66f1964437546376eaa617dd3903bb5f16afc69011a6d8263783813ada3f"},{"ts":"2026-07-17T02:41:55.695Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-nerve-damage","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8daa66f1964437546376eaa617dd3903bb5f16afc69011a6d8263783813ada3f","hash":"df1756db141df0ef9c37f786e48c0d1e103140f0a6f5e587342f1842962e7f86"}]}